GRFS
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: —
# of Employee: 14,700 / Fiscal Year End: 2016-12-31 / Stock Type: Large Growth
EUR / Exchange Rate: 0.941002219 at 2016-11-22 / Estimation: $Confidential / / $

Grifols SA is a specialty biopharmaceutical company that develops, manufactures and distributes a broad range of plasma derivative products. It operates in four business divisions: Bioscience, Diagnostic, Hospital and Raw Materials.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | VRTX | INCY | BMRN | VVUS |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2016-12-25Quarter1,163,711,674.4631,172,155.858,683,006.9147,333,270.1147,679,792.0671,788,63345.80%12.70%12.70%
2017-03-25Quarter1,125,062,296.0550,814,045.10.0141,718,979.5141,992,382.1669,965,k51.00%12.60%12.60%
2017-06-25Quarter1,198,273,789.9603,459,941.170,377,856.1152,210,009.5152,456,919.6685,085,71449.60%12.70%12.70%
2017-09-25Quarter1,120,882,839.2557,817,602.40.0162,515,592.0163,089,949.4700,594,77450.20%14.50%14.60%
2017-12-25Quarter1,131,643,033.0583,284,312.80.0244,349,864.8244,723,938.9683,257,10248.50%21.60%21.60%
2018-03-25Quarter1,084,085,816.4566,068,426.667,346,054.4151,399,339.0151,968,397.9683,736,45747.80%14.00%14.00%
2018-06-25Quarter1,162,603,228.2614,286,896.070,694,706.4185,460,216.4186,053,648.4675,276,92347.20%16.00%16.00%
2018-09-25Quarter1,212,084,860.0655,464,718.60.0157,477,778.2158,232,284.6683,737,76345.90%13.00%13.10%
2018-12-25Quarter1,295,807,518.2746,842,649.60.0135,553,644.9136,007,196.5702,763,59542.40%10.50%10.50%
2019-03-25Quarter1,225,836,586.9666,258,822.80.0121,102,516.0121,196,829.3684,135,34545.60%9.90%9.90%
2019-06-25Quarter1,342,198,005.1708,609,733.382,402,272.0191,124,312.9182,807,787.3690,036,k47.20%14.20%13.60%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2017-12-25Quarter-2.76%-7.59%-100.00%65.85%65.71%1.71%5.90%70.08%70.08%
2018-03-25Quarter-3.64%2.77%0.00%6.83%7.03%2.06%-6.27%11.11%11.11%
2018-06-25Quarter-2.98%1.79%0.45%21.84%22.04%-1.43%-4.84%25.98%25.98%
2018-09-25Quarter8.14%17.51%0.00%-3.10%-2.98%-2.41%-8.57%-10.34%-10.27%
2018-12-25Quarter14.51%28.04%0.00%-44.52%-44.42%2.85%-12.58%-51.39%-51.39%
2019-03-25Quarter13.08%17.70%-100.00%-20.01%-20.25%0.06%-4.60%-29.29%-29.29%
2019-06-25Quarter15.45%15.35%16.56%3.05%-1.74%2.19%0.00%-11.25%-15.00%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter3,943,653,415.710,734,519,388.46,790,865,972.73,308,928,085.81,135,747,251.15,655,118,721.6.581.343
2017-03-25Quarter4,037,914,790.412,407,346,972.68,369,432,182.23,128,414,549.01,001,244,828.67,368,187,353.6.482.320
2017-06-25Quarter3,792,710,807.411,780,662,646.37,987,951,838.93,021,238,610.4954,070,163.77,033,881,675.2.475.316
2017-09-25Quarter3,796,575,533.311,667,232,358.37,870,656,825.03,089,782,125.81,008,905,399.96,861,751,425.1.482.327
2017-12-25Quarter3,845,735,016.311,572,203,760.87,726,468,744.53,121,151,365.21,036,372,823.96,690,095,920.6.498.332
2018-03-25Quarter3,926,620,857.611,524,480,171.37,597,859,313.73,142,934,558.41,004,633,749.26,593,225,564.5.517.320
2018-06-25Quarter4,204,253,780.012,116,206,054.37,911,952,274.33,123,331,168.11,076,326,693.06,835,625,581.3.531.345
2018-09-25Quarter4,392,484,052.212,482,921,597.58,090,437,545.33,204,931,247.21,151,279,274.06,939,158,271.3.543.359
2018-12-25Quarter4,477,819,573.813,221,925,646.28,744,106,072.43,691,201,084.71,332,383,063.77,411,723,008.7.512.361
2019-03-25Quarter4,663,897,595.314,186,272,780.59,522,375,185.23,697,257,270.21,287,652,067.08,234,723,118.2.490.348
2019-06-25Quarter43,190,192.90.00.09,463,132,656.741,785,030.7568,786,557.1∞.004

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-2.48%7.80%13.78%-5.67%-8.75%18.30%-14.29%-3.21%
2018-03-25Quarter-2.76%-7.12%-9.22%0.46%0.34%-10.52%7.26%0.00%
2018-06-25Quarter10.85%2.85%-0.95%3.38%12.81%-2.82%11.79%9.18%
2018-09-25Quarter15.70%6.99%2.79%3.73%14.11%1.13%12.66%9.79%
2018-12-25Quarter16.44%14.26%13.17%18.26%28.56%10.79%2.81%8.73%
2019-03-25Quarter18.78%23.10%25.33%17.64%28.17%24.90%-5.22%8.75%
2019-06-25Quarter-98.97%-100.00%-100.00%202.98%-96.12%-91.68%-100.00%-98.84%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note